Acute phase 2–30 days (N = 9958) | Post acute phase 31–365 days (N = 7984) | |||||
---|---|---|---|---|---|---|
% of patients | ORadj a | p value | % of patients | ORadj a | p value | |
Sex | ||||||
Women vs Men | 50.0 | 1.18 | 0.010 | 47.3 | 1.02 | 0.824 |
Age in years | ||||||
35–65 | 18.1 | 1.00 | <.0001c | 21.6 | 1.00 | <.0001c |
66–75 | 23.2 | 2.45 | <.0001 | 25.9 | 2.24 | <.0001 |
76–85 | 38.2 | 5.20 | <.0001 | 37.7 | 3.75 | <.0001 |
85+ | 20.4 | 11.17 | <.0001 | 14.8 | 7.96 | <.0001 |
Education level | ||||||
Elementary | 53.3 | 1.00 | 0.038c | 49.5 | 1.00 | 0.101c |
Medium | 28.7 | 0.88 | 0.132 | 30.7 | 0.87 | 0.123 |
High | 14.8 | 0.71 | 0.004 | 16.4 | 0.81 | 0.092 |
University | 3.2 | 0.69 | 0.096 | 3.4 | 0.55 | 0.021 |
Care-Pathway | ||||||
Hospital Performance | ||||||
Medium | 38.5 | 1.00 | 0.025c | 37.6 | 1.00 | 0.523c |
High | 41.6 | 0.70 | 0.006 | 43.9 | 0.82 | 0.106 |
Low | 19.9 | 1.21 | 0.156 | 18.6 | 0.99 | 0.917 |
Access to rehabilitation | 33.0 | 0.93 | 0.402 | |||
Treatment post-dischargeb | ||||||
Three drugs | 23.0 | 1.00 | <.0001c | |||
Two drugs | 27.7 | 1.58 | <.0001 | |||
One drugs | 15.5 | 2.15 | <.0001 | |||
No drugs | 33.7 | 3.43 | <.0001 | |||
p-value (test di Wald) | 0.014 | 0.029 |